These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29954600)

  • 1. Comparison of Lipoprotein(a)-Levels in Patients ≥70 Years of Age With Versus Without Aortic Valve Stenosis.
    Mahabadi AA; Kahlert P; Kahlert HA; Dykun I; Balcer B; Forsting M; Heusch G; Rassaf T
    Am J Cardiol; 2018 Aug; 122(4):645-649. PubMed ID: 29954600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological significance of lipoprotein(a) in aortic valve stenosis.
    Yu B; Khan K; Hamid Q; Mardini A; Siddique A; Aguilar-Gonzalez LP; Makhoul G; Alaws H; Genest J; Thanassoulis G; Cecere R; Schwertani A
    Atherosclerosis; 2018 May; 272():168-174. PubMed ID: 29614432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
    J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
    Vongpromek R; Bos S; Ten Kate GJ; Yahya R; Verhoeven AJ; de Feyter PJ; Kronenberg F; Roeters van Lennep JE; Sijbrands EJ; Mulder MT
    J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Ma GS; Wilkinson MJ; Reeves RR; Yeang C; DeMaria AN; Cotter B; Patel M; Mahmud E; Tsimikas S
    Angiology; 2019 Apr; 70(4):332-336. PubMed ID: 30700108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.
    Marrero N; Jha K; Razavi AC; Boakye E; Anchouche K; Dzaye O; Budoff MJ; Tsai MY; Shah SJ; Rotter JI; Guo X; Yao J; Blumenthal RS; Thanassoulis G; Post WS; Blaha MJ; Whelton SP
    Circ Cardiovasc Imaging; 2024 Jun; 17(6):e016372. PubMed ID: 38889215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.
    Zheng KH; Arsenault BJ; Kaiser Y; Khaw KT; Wareham NJ; Stroes ESG; Boekholdt SM
    J Am Heart Assoc; 2019 Aug; 8(16):e013020. PubMed ID: 31407609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
    Bordalo AD; Nobre AL; Dantas M; Cravino J
    Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis.
    Cao J; Steffen BT; Budoff M; Post WS; Thanassoulis G; Kestenbaum B; McConnell JP; Warnick R; Guan W; Tsai MY
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1003-9. PubMed ID: 26941019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
    Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does aortic valve sclerosis predicts the severity and complexity of coronary artery disease?
    Bhatt H; Sanghani D; Julliard K; Fernaine G
    Indian Heart J; 2015; 67(3):239-44. PubMed ID: 26138181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
    Hung MY; Tsimikas S
    Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
    Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
    J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease.
    Ljungberg J; Holmgren A; Bergdahl IA; Hultdin J; Norberg M; Näslund U; Johansson B; Söderberg S
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.
    Perrot N; Thériault S; Dina C; Chen HY; Boekholdt SM; Rigade S; Després AA; Poulin A; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Khaw KT; Wareham NJ; Dweck MR; Mathieu P; Pibarot P; Schott JJ; Thanassoulis G; Clavel MA; Bossé Y; Arsenault BJ
    JAMA Cardiol; 2019 Jul; 4(7):620-627. PubMed ID: 31141105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease.
    Kaltoft M; Langsted A; Afzal S; Kamstrup PR; Nordestgaard BG
    J Am Coll Cardiol; 2022 Feb; 79(6):545-558. PubMed ID: 35144746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.